ClinicalTrials.Veeva

Menu

Follicular Activation by Fragmentation of Ovarian Tissue (FAFOT)

P

Podobnik Maternity and Gynecology Hospital

Status

Unknown

Conditions

Diminished Ovarian Reserve

Treatments

Procedure: Ovarian tissue fragmentation

Study type

Interventional

Funder types

Other

Identifiers

NCT03670407
201810001

Details and patient eligibility

About

The primary objective of this study is to assess the chances of increasing the number of antral follicles in ovarian tissue of patients with diminished ovarian reserve by activation of primordial follicles through ovarian cortex fragmentation. Secondary objectives are to assess potential association with the number of oocytes retrieved and pregnancy rates after IVF.

Enrollment

40 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. previous ≥ 2 poor ovarian responds (≤ 3 retrieved oocytes) in an antagonist cycle with a minimum of 225 IU gonadotropins a day or corifollitropin 150 mcg) in patients >35 i <40 years
  2. previous cycle with ≤ 3 retrieved oocytes) in an antagonist cycle with a minimum of 225 IU gonadotropins a day or corifollitropin 150 mcg) in patients >35 i <40 years with antral follicle count (AFC) ≤ 5 i/ili antiM¸ulelrian hormone (AMH) ≤ 6.5pmol/L
  3. premature ovarian insufficiency according to European Society of Human Reproduction and Embryology (ESHRE) development group, 2015 in patients 18-40 years
  4. undetectable AMH serum levels and follitropin (FSH) >35 IU/ml in two serum samples separated by at least 4 weeks

Exclusion criteria

  1. clinical/ultrasonographical signs of endometriosis
  2. previous ovarian/pelvic surgery
  3. previous gonadotoxic treatment
  4. genito-urinary tract malformations
  5. extreme male infertility ( <10 000 progressively motile sperms in the semen sample)
  6. inform consent unsigned -

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control group
No Intervention group
Description:
Participants who opt not to go ahead with ovarian fragmentation.
Study group
Experimental group
Description:
Participants who opt for ovarian fragmentation.
Treatment:
Procedure: Ovarian tissue fragmentation

Trial contacts and locations

1

Loading...

Central trial contact

Milan D Milenkovic, MD, PhD; Miro S Alebić, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems